Unknown

Dataset Information

Characterizing Phage Genomes for Therapeutic Applications.


ABSTRACT: Multi-drug resistance is increasing at alarming rates. The efficacy of phage therapy, treating bacterial infections with bacteriophages alone or in combination with traditional antibiotics, has been demonstrated in emergency cases in the United States and in other countries, however remains to be approved for wide-spread use in the US. One limiting factor is a lack of guidelines for assessing the genomic safety of phage candidates. We present the phage characterization workflow used by our team to generate data for submitting phages to the Federal Drug Administration (FDA) for authorized use. Essential analysis checkpoints and warnings are detailed for obtaining high-quality genomes, excluding undesirable candidates, rigorously assessing a phage genome for safety and evaluating sequencing

SUBMITTER: Philipson CW 

PROVIDER: S-EPMC5923482 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature